Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/34850
Title: CANOPY-1: A phase III, placebo-controlled study of pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) with/without canakinumab in untreated patients (pts) with stage IIIB/IIIC-IV NSCLC
Authors: TAN, D. S. W.KIM, T. M.SOLOMON, B. J.TAN, W. L.YU, C-J.GEATER, S.CASTRO JR., G. DeGREYSTOKE, A.FELIP, E.JOHNSON, B. E.DEUDON, S.LOUVEAU, A-L.PASSOS, V. Q.CHO, B. C.
Citation: ANNALS OF ONCOLOGY, v.30, suppl.9, 2019
Appears in Collections:

Comunicações em Eventos - FM/MDR
Departamento de Radiologia - FM/MDR

Comunicações em Eventos - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Comunicações em Eventos - LIM/24
LIM/24 - Laboratório de Oncologia Experimental


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.